ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends VRAYQ vs. IONM, GMVDF, AHPI, BRSH, MOTS, DRTSW, ANZUW, ATAKW, BBLGW, and BRSHWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Assure (IONM), G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Bruush Oral Care (BRSH), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), and Bruush Oral Care (BRSHW). These companies are all part of the "medical equipment" industry. ViewRay vs. Assure G Medical Innovations Allied Healthcare Products Bruush Oral Care Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care ViewRay (NASDAQ:VRAYQ) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, community ranking, risk, earnings, dividends and valuation. Which has more volatility & risk, VRAYQ or IONM? ViewRay has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Assure has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500. Which has better earnings & valuation, VRAYQ or IONM? Assure has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/AAssure$250K0.13-$26.08MN/AN/A Does the MarketBeat Community favor VRAYQ or IONM? Assure received 3 more outperform votes than ViewRay when rated by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/AAssureOutperform Votes327.27% Underperform Votes872.73% Is VRAYQ or IONM more profitable? ViewRay has a net margin of 0.00% compared to Assure's net margin of -25,178.32%. Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A Assure -25,178.32%N/A -249.78% Do institutionals & insiders hold more shares of VRAYQ or IONM? 15.5% of ViewRay shares are held by institutional investors. Comparatively, 3.3% of Assure shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 3.8% of Assure shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor VRAYQ or IONM? In the previous week, Assure had 1 more articles in the media than ViewRay. MarketBeat recorded 1 mentions for Assure and 0 mentions for ViewRay. Assure's average media sentiment score of 0.76 beat ViewRay's score of 0.00 indicating that Assure is being referred to more favorably in the news media. Company Overall Sentiment ViewRay Neutral Assure Positive SummaryAssure beats ViewRay on 6 of the 10 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$20,000.00$3.54B$5.39B$9.13BDividend YieldN/A1.66%5.37%4.00%P/E RatioN/A18.4188.8317.53Price / SalesN/A59.091,282.2680.28Price / CashN/A39.0936.6032.90Price / BookN/A3.974.964.69Net Income-$107.33M$94.49M$117.89M$224.57M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$20,000.00$102.21M0.00300IONMAssureN/A$0.01flatN/AN/A$31,000.00$250,000.000.00130GMVDFG Medical InnovationsN/AN/AN/AN/A$30,000.00$4.42M0.0072AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150BRSHBruush Oral CareN/A$0.00-18.2%N/A-98.7%$1,000.00$2.92M0.0011MOTSMotus GIN/A$0.00flatN/A-100.0%$1,000.00$320,000.000.0030DRTSWAlpha Tau MedicalN/A$0.31-6.1%N/A+9.8%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.05-9.8%N/AN/A$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/AN/AN/AN/A$0.00N/A0.00N/AGap UpHigh Trading VolumeBBLGWBone BiologicsN/A$62.20+5.1%N/A+993.1%$0.00N/A0.002Positive NewsGap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011News Coverage Related Companies and Tools Related Companies Assure Alternatives G Medical Innovations Alternatives Allied Healthcare Products Alternatives Bruush Oral Care Alternatives Motus GI Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VRAYQ) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRAYQ Stock Alerts